A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Head and Neck Cancer · Head Cancer · Head Cancer Neck · Neck Cancer · Head and Neck Squamous Cell Carcinoma · HNSCC

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Lara Dunn, MD) · dunnl1@mskcc.org · 646-608-3787
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Lara Dunn, MD) · 646-608-3787
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Lara Dunn, MD) · 646-608-3787
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only), Commack, New York, United States

    Contact: Study coordinator (Laura Dunn, MD) · 646-608-3787
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Lara Dunn, MD) · 646-608-3787
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Lara Dunn, MD) · 646-608-3787
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre, New York, United States

    Contact: Study coordinator (Laura Dunn, MD) · 646-608-3787
Study leads
  • Lara Dunn, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center